Cambium Bio Limited has released a press release.
Kyocera completes Progenza Due Diligence
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cambium Bio
- Appendix 4C Updated
- Regeneus to be granted new key Progenza patent in U.S.
- Regeneus receives A$1.6M milestone payment from Kyocera
- Regeneus signs MOU with Kyocera Corporation
- Half-Year Results & Business Update
Later from Cambium Bio
- Progenza OA Kyocera negotiations update
- Regeneus and Kyocera sign Progenza OA deal
- US Patent for Sygenus
- Regeneus to present at FNN Virtual Investor Event
- Appendix 4E and Annual Report
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio